ATRA vs MOS · rev $128.9M vs P/E 161, rev $11.12B
Atara Biotherapeutics Inc (ATRA) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ATRA currently screens at market cap $87.1M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ATRA and MOS stock pages for the full models.
Not investment advice.